Literature DB >> 9821472

Local immunotherapy.

H J Malling1, J Abreu-Nogueira, E Alvarez-Cuesta, B Björkstén, J Bousquet, D Caillot, G W Canonica, G Passalacqua, P Saxonis-Papageorgiou, E Valovirta.   

Abstract

Mesh：

Year:  1998        PMID： 9821472     DOI： 10.1111/j.1398-9995.1998.tb03793.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  10 in total

Review 1.  Pollen immunotherapy: selection,prevention, and future directions.

Authors:  Steven J McEldowney; Robert K Bush
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

2.  Sub-lingual immunotherapy: world allergy organization position paper 2009.

Authors:  G Walter Canonica; Jean Bousquet; Thomas Casale; Richard F Lockey; Carlos E Baena-Cagnani; Ruby Pawankar; Paul C Potter; Philippe J Bousquet; Linda S Cox; Stephen R Durham; Harold S Nelson; Giovanni Passalacqua; Dermot P Ryan; Jan L Brozek; Enrico Compalati; Ronald Dahl; Luis Delgado; Roy Gerth van Wijk; Richard G Gower; Dennis K Ledford; Nelson Rosario Filho; Erkka J Valovirta; Osman M Yusuf; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2009-11-19       Impact factor: 4.084

3.  Effects of Local Nasal Immunotherapy with FIP-fve Peptide and Denatured Tyrophagus putrescentiae for Storage Mite-Induced Airway Inflammation.

Authors:  Chung-Yang Yen; Ching-Hsiang Yu; Jaw-Ji Tsai; Hsiang-Kuang Tseng; En-Chih Liao
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2022-01-31       Impact factor: 4.291

4.  Specific immunotherapy-indications and mode of action.

Authors:  Randolf Brehler; Ludger Klimek; Matthias Volkmar Kopp; Johann Christian Virchow
Journal:  Dtsch Arztebl Int       Date:  2013-03-01       Impact factor: 5.594

5.  Local nasal specific immunotherapy for allergic rhinitis.

Authors:  Giovanni Passalacqua; Giorgio Walter Canonica
Journal:  Allergy Asthma Clin Immunol       Date:  2006-09-15       Impact factor: 3.406

6.  Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI).

Authors:  Eric Leith; Tom Bowen; Joe Butchey; David Fischer; Harold Kim; Bill Moote; Peter Small; Don Stark; Susan Waserman
Journal:  Allergy Asthma Clin Immunol       Date:  2006-06-15       Impact factor: 3.406

Review 7.  [Specific immunotherapy. Hyposensitization with allergens].

Authors:  B Wedi; A Kapp
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

8.  Sublingual immunotherapy: World Allergy Organization position paper 2013 update.

Authors:  Giorgio Walter Canonica; Linda Cox; Ruby Pawankar; Carlos E Baena-Cagnani; Michael Blaiss; Sergio Bonini; Jean Bousquet; Moises Calderón; Enrico Compalati; Stephen R Durham; Roy Gerth van Wijk; Désirée Larenas-Linnemann; Harold Nelson; Giovanni Passalacqua; Oliver Pfaar; Nelson Rosário; Dermot Ryan; Lanny Rosenwasser; Peter Schmid-Grendelmeier; Gianenrico Senna; Erkka Valovirta; Hugo Van Bever; Pakit Vichyanond; Ulrich Wahn; Osman Yusuf
Journal:  World Allergy Organ J       Date:  2014-03-28       Impact factor: 4.084

Review 9.  Immunotherapy for rhinitis.

Authors:  Hans-Jørgen Malling
Journal:  Curr Allergy Asthma Rep       Date:  2003-05       Impact factor: 4.919

10.  Is sublingual immunotherapy the final answer? Implications for the allergist.

Authors:  Giorgio Walter Canonica; Giovanni Passalacqua
Journal:  World Allergy Organ J       Date:  2008-04       Impact factor: 4.084
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.